Business Context and Reporting Period
Company: SciSparc Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: October 2023 (Report dated October 12, 2023)
Principal Executive Offices: Tel Aviv, Israel
The filing discloses a material corporate event: the entry into a private placement transaction on October 11, 2023, with an institutional investor. The transaction is expected to close on October 13, 2023.
Key Financial Metrics
This filing reports on a capital raise event rather than operational financial performance. Consequently, revenue, profit, operating cash flow, and margins are not disclosed in this document.
- Gross Proceeds: $5,026,000
- Aggregate Purchase Price: $7,180,000
- Original Issue Discount (OID): 30%
- Placement Fee: 8.0% of gross cash proceeds
- Legal Expense Cap: Up to $75,000
- Use of Proceeds: General corporate purposes, including working capital
Material Changes and Transaction Details
The primary material change is the issuance of securities to raise capital. The transaction structure includes:
- Securities Issued: Units consisting of 1,930,108 pre-funded ordinary share purchase warrants (Pre-Funded Warrants) and an accompanying warrant.
- Purchase Price: $3.72 per Unit.
- Underlying Shares: The Pre-Funded Warrants allow the purchase of up to 1,930,108 ordinary shares.
- Warrant Terms: Immediately exercisable at $0.001 per share with a five-year term.
- Confession of Judgment: The Company executed a Confession of Judgment in favor of the Purchaser for the fair market value of shares upon exercise notice.
- Registration Rights: The Company agreed to file a registration statement with the SEC for the resale of the ordinary shares.
Guidance, Outlook, and Risks
Management Commentary: Management intends to use net proceeds for working capital and general corporate purposes. The closing is subject to customary conditions.
Risks and Contingencies:
- Forward-Looking Statements: The filing contains forward-looking statements regarding the closing of the offering and use of proceeds, which are subject to risks and uncertainties.
- Market Risks: Actual results may differ materially from expectations due to inherent uncertainties.
- Legal Risks: The securities are unregistered under the Securities Act of 1933 and cannot be sold in the U.S. absent registration or exemption.
- Confession of Judgment: The Company has confessed judgment in favor of the Purchaser, creating a specific legal contingency tied to warrant exercise.
Investor Verification Checklist
- Verify the actual closing date of the private placement (expected October 13, 2023).
- Confirm the final net proceeds after deducting the 8.0% placement fee and legal expenses.
- Review the full text of the Securities Purchase Agreement and Confession of Judgment (Exhibits 10.1 and 10.3) for specific covenants.
- Monitor the filing of the registration statement for the resale of ordinary shares as promised by management.
- Check subsequent filings for any updates on the use of proceeds or changes in the company's liquidity position.